In lab dishes, Liu's team corrected a mutation in
human cells from a patient with an iron - storage blood disorder called hereditary hemochromatosis.
«It is exciting that they have generated
human cells from the patient material,» says stem cell researcher Jeffrey Rothstein of Johns Hopkins University in Baltimore, Maryland, who also studies ALS.
Not exact matches
As we read this history, the furor over stem
cells was fueled by numerous factors: the near - universal
human desire for magic;
patients» desperation in the face of illness and their hope for cures; the belief that biology can now do anything; the reluctance of scientists to accept any limits (particularly moral limits) on their research; the impact of big money
from biotech stocks, patents, and federal funding; the willingness of America's elite class to use every means possible to discredit religion in general; and the need to protect the unlimited abortion license by accepting no protections of unborn
human life.
They stripped the knee joints of calves of all their
cells with detergents and enzymes and then, based on digitized x-ray images
from an anonymous
patient, had machines carve them into cubic - centimeter - size
human jaw joints.
«I'm working with Professor Richard Oreffo and Dr Rahul Tare
from the University's Centre for
Human Development, Stem
Cells and Regeneration who are trying to create and grow cartilage in the lab using a patients» own (autologous) stem cells to then be implanted back into the patient if they have a cartilage defect,» she expl
Cells and Regeneration who are trying to create and grow cartilage in the lab using a
patients» own (autologous) stem
cells to then be implanted back into the patient if they have a cartilage defect,» she expl
cells to then be implanted back into the
patient if they have a cartilage defect,» she explains.
The Porteus team started with
human stem
cells from the blood of
patients with sickle
cell disease, corrected the gene mutation using CRISPR and then concentrated the
human stem
cells so that 90 percent carried the corrected sickle
cell gene.
If the procedure works in
humans, it would enable donated livers
from humans, and possibly even
from pigs, to be re-coated with a
patient's own
cells, reducing the likelihood of organ rejection.
HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers
from the Department of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at
human brain tumor samples and discovered that specialized immune
cells in brain tumor
patients are compromised.
Abba Zubair, M.D., Ph.D, believes that
cells grown in the International Space Station (ISS) could help
patients recover
from a stroke, and that it may even be possible to generate
human tissues and organs in space.
These techniques include:
human tissue created by reprogramming
cells from people with the relevant disease (dubbed «
patient in a dish»); «body on a chip» devices, where
human tissue samples on a silicon chip are linked by a circulating blood substitute; many computer modelling approaches, such as virtual organs, virtual
patients and virtual clinical trials; and microdosing studies, where tiny doses of drugs given to volunteers allow scientists to study their metabolism in
humans, safely and with unsurpassed accuracy.
Currently, Deng's laboratory is conducting additional preclinical studies using the
human - derived stem
cells from Down syndrome
patients and mouse models to determine whether cellular and behavioral abnormalities can be improved with minocycline therapy and other candidate drugs.
In addition to looking at mouse models of diabetes, the researchers also showed that exposure of
human pancreatic islet
cells — both
from healthy donors and
from patients with Type 1 diabetes — to fasting - mimicking diet in a dish stimulated insulin production.
By promoting DNA demethylation, high - dose vitamin C treatment induced stem
cells to mature, and also suppressed the growth of leukemia cancer stem
cells from human patients implanted in mice.
Pre-clinical studies have shown it to be effective in eliminating a number of different kinds of cancers
cells, including cancer stem
cells from human breast cancer
patient biopsies.
In
humans, a comparison of bone marrow
from 14 normal bone marrow donors, 35 multiple myeloma
patients and 11
patients with a noncancerous condition called monoclonal gammopathy of undetermined significance (MGUS) showed that Runx2 levels were significantly higher in the multiple myeloma
cells.
We also reactivated insulin production in
human pancreatic
cells from type 1 diabetes
patients.»
In this study, researchers took
cells from patients with blood cancer MDS and turned them into stem
cells to study the deletions of
human chromosome 7 often associated with this disease.
They found out that TiY is capable of distinguishing TICs
from non-TICs in various
human lung cancer
cell lines and
patient - derived lung tumors.
By assessing the survival of the
cells that engulf the particles and measuring the levels of red or green light that they emitted, the researchers determined which formulation of particles performed best, then tested that formulation in mice with
human brain cancer derived
from their
patients.
Desgrosellier said the team will follow up with mouse models containing tumor fragments
from patients to better reflect the diversity of
cell types present in
human disease.
Unlike the skin
cells from which they originated, the
human iPS
cells created
from FOP
patients show increased cartilage formation and increased bone mineralization, two critical steps that are necessary to form mature bone.
Scientists want to be able to clone early
human embryos, using
cells from patients with various diseases, so they can study the diseases in the lab and develop new treatments for them.
To see if PGD and the pentose phosphate pathway were tied to the epigenetic changes the researchers had detected in distant metastases, they treated tumor
cells from different sites in a single
patient with the drug 6 - aminonicotinamide (6AN), which is known to inhibit PGD but is not used in
humans because of its severe side effects.
After running the simulations at IU Bloomington, Bacallao confirmed the cyst growth predictions seen in the virtual cysts in experiments using real
human cells cultivated
from polycystic kidneys
from patients at the IU School of Medicine.
Now he and his team are putting
cells from human brain tumors into the organoids, which have reached the level of development and complexity of a 20 - week - old
human fetus's, to see whether they reprise what happens in
patients.
«By analyzing mice with the WNT10A mutation, as well as tissues
from human patients with WNT10A mutations, we found that WNT10A regulates the proliferation, but not the maintenance, of stem
cells in hair follicles,» said Sarah Millar, PhD, vice chair for Basic Research in the Department of Dermatology.
Instead of using these invasive and complicated procedures to obtain
cells from hypercholesterolemic
patients, Dr Si - Tayeb decided to use a more convenient source of
human cells: urine.
The bacterial peptide found to activate MS
patients» T
cells came
from Pseudomonas aeruginosa, a common inhabitant of
human skin which can infect wounds.
Strikingly, the researchers noticed the same signs of axonal demise in spinal cord
cells obtained
from human patients with ALS.
Alternative
cell lines, such as induced pluripotent stem
cells generated
from patient skin
cells, offer a more accurate window on
human biology, he says.
To test this, the researchers did a side - by - side comparison with
cells isolated
from elephants (n = 8), healthy
humans (n = 10), and
from patients with Li - Fraumeni Syndrome (n = 10).
That finding indicates that very low numbers of the
cells in the body could be enough to protect
human patients from maladies ranging
from infections to cancer.
They will study
human macrophages and dendritic
cells isolated
from IBD
patients with defective GM - CSF function, «The approach represents a step forward in personalizing how we treat
patients with IBD,» said Dr. Colombel.
The researchers, led by University of California, San Diego neuroscientist Mark Tuszynski, took skin
cells from the
patients, grew them up in a culture dish and genetically engineered them to make
human nerve growth factor (NGF).
Karnoub quickly closes the lid and explains that the
human cells he tests were removed
from patients during surgery or
from biopsy specimens.
Over the past two years, investigators
from the Perelman School of Medicine at the University of Pennsylvania have reported results
from a
human trial in GBM using chimeric antigen receptor (CAR) T
cell therapy, through which
patients» own T
cells were engineered to track down and kill cancer
cells that express a tumor - specific protein known as EGFRvIII.
In a letter published in the cancer journal Annals of Oncology, researchers led by Professor Jean - Philippe Spano, head of the medical oncology department at Pitie - Salpetriere Hospital AP - HP in Paris, France, report that while treating an HIV - infected lung cancer
patient with the cancer drug nivolumab, they observed a «drastic and persistent decrease» in the reservoirs of
cells in the body where the
human immunodeficiency virus (HIV) is able to hide away
from attack by anti-retroviral therapy.
Although this
human Gut Chip recreated the villus epithelium of normal intestine and enabled new insights into how flow and cyclic peristalsis affects intestinal differentiation and function, it could not be used to study processes that relied on normal intestinal
cells from individual donors, which, for example, is crucial for studying
patient - specific responses for personalized medicine.
One is using
cells derived
from human embryonic stem
cells to treat spinal cord injury (although funding problems have stopped the trial enrolling new
patients) and another is testing a treatment for age - related macular degeneration.
In the new work, the researchers added serum
from Finnish narcolepsy
patients who had received Pandemrix to
cells that were engineered to display
human hypo cretin receptor 2 on their surface.
To uncover the identities and roles of these channels in
humans, Donald Welsh and colleagues
from the University of Calgary investigated smooth muscle
cells from cerebral arteries harvested
from patients undergoing brain surgery.
ACT announced last November that they had cloned early - stage
human embryos in a step toward therapeutic cloning (which seeks to treat diseases by using genetic material
from a
patient's own
cells) but the company believes that reproductive cloning is too risky and unwarranted at this time.
After confirming in mouse models that
cells from HER2 - positive breast cancers became resistant to anti-HER2 treatment when implanted into the brain but not into other tissues, the investigators found that HER3 is overexpressed in brain metastases of HER2 - positive breast cancers
from both mice and
human patients.
Palanichamy, Chakravarti and their colleagues conducted this study using 13 primary GBM
cell lines derived
from patient tumors, four commercially available GBM
cell lines and normal
human astrocyte
cells.
«We used
human skin
cells that we obtained
from patients affected with ALS and converted them into neurons via a technology called induced pluripotent stem
cell production,» she explains.
In the new paper, Sahin and colleagues took their observations to
humans, studying Purkinje
cells derived
from three
patients with TSC (two also had ASD symptoms, and all three also had epilepsy).
The researchers studied tumour tissue
from patients, cultivated
human tumour
cells and tumours in mouse models for neuroblastoma.
In the first published results
from a clinical trial using
human embryonic stem
cells, two legally blind
patients who received an injection of hESC - derived
cells in one eye have experienced no harmful side effects and appear to have slightly better vision.
Earlier this year, scientists at University of California, Los Angeles, and Advanced
Cell Technology of Marlborough, Massachusetts, reported in The Lancet about the safe and successful use of RPE
cells derived
from human embryonic stem
cells, rather than iPS
cells, to treat a different type of AMD in a limited number of
human patients.
One team in Japan, and another in the US, have independently shown it is possible to produce embryonic - like stem
cells directly
from a
patient's own skin
cells without having to create and destroy a cloned
human embryo first.